Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Tecan reports positive fiscal data during H1 2012

Tecan reports positive fiscal data during H1 2012

20th August 2012

Tecan has published its financial results for the first half of 2012, during which it experienced a continued improvement in its operational performance.

The life science company's sales for the period came to 182.2 million Swiss francs (119.22 million pounds), up by 0.2 percent year-on-year, while its operating profit level rose by 6.3 percent.

In the third quarter, the company expects to experience an acceleration in growth, thanks to its project pipeline, order backlog and contributions from the launch of an exciting alternative pipetting technology.

As such, Tecan is confident that it will be able to successfully meet its guidance for the 2012 full-year period.

Gerard Vaillant, acting chief executive officer (CEO) of Tecan, said: "We are pleased with … the fact that we were able to moderately grow sales above the high level we reached last year, despite the challenging economic environment."

The organisation is currently awaiting Dr David Martyr being able to take up his confirmed position as its new permanent CEO, as soon as his current contractual obligations permit.ADNFCR-8000103-ID-801432703-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.